Dizal (Jiangsu) Pharmaceutical Co., Ltd. (SHA:688192)
China · Delayed Price · Currency is CNY 57.79
-2.41 (-4.00%)
Aug 26, 2026, 4:00 PM EDT
SHA:688192 Market Cap
SHA:688192 has a market cap or net worth of 26.88 billion as of August 26, 2026. Its market cap has decreased by -29.37% in one year.
Market Cap
26.88B
Enterprise Value
26.50B
Revenue
968.83M
Ranking
n/a
PE Ratio
n/a
Stock Price
57.79
ChartMarket Cap Chart
Since December 10, 2021, SHA:688192's market cap has increased from 16.44B to 26.88B, an increase of 63.52%. That is a compound annual growth rate of 11.00%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 26, 2026 | 26.88B | 1.20% |
| Dec 31, 2025 | 26.56B | 54.11% |
| Dec 31, 2024 | 17.24B | -11.74% |
| Dec 29, 2023 | 19.53B | 21.84% |
| Dec 30, 2022 | 16.03B | 7.16% |
| Dec 31, 2021 | 14.96B | -9.01% |
| Dec 10, 2021 | 16.44B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Beijing Tongrentang | 33.26B |
| Changchun High-Tech Industry (Group) | 32.06B |
| Dong-E-E-Jiao | 31.20B |
| Humanwell Healthcare (Group) | 29.41B |
| Shijiazhuang Yiling Pharmaceutical | 26.88B |
| Zhejiang Huahai Pharmaceutical | 24.48B |
| Tianjin Pharmaceutical Da Ren Tang Group Corporation | 24.00B |
| Apeloa Pharmaceutical Co.,Ltd | 23.49B |